Enhancement of chlorpromazine efficacy in breast cancer treatment by 266 nm laser irradiation Authors: Ana Maria Udrea, Angela Staicu, Adriana Smarandache, Ionut Relu Andrei, Madalina Andreea Badea, Speranta Avram, Mihail Lucian Pascu, Ruxandra Angela Pirvulescu, Mihaela Balas Published: 2024 ABSTRACT AbstractBreast cancer remains a global health challenge, prompting interest in the anticancer properties of other drugs, including chlorpromazine (CPZ). This study presents a novel approach in breast cancer treatment using laser irradiated CPZ. CPZ dissolved in distilled water, was exposed to 266 nm laser irradiation for varying durations, characterized by UV-Vis and FTIR spectroscopy, followed by drug-likeness and ADME-Tox predictions. In vitro assays evaluated the cytotoxicity and cellular effects on MCF-7 breast cancer cells, and compared with MCF-12 A healthy cell line. Laser irradiation altered CPZ molecular structure resulting in photoproducts with favourable drug-like properties and ADME-Tox profiles. In vitro evaluations demonstrate dose and irradiation time-dependent cytotoxicity against breast cancer cells, and reduced toxicity on healthy cell line. Significant alterations in F-actin organization, and excessive ROS generation were also proved, suggesting the potential of laser-modified CPZ for breast cancer therapy. This study introduces a novel approach to breast cancer treatment through laser irradiated CPZ, highlighting promising advancements in therapy and emphasizing the role of laser-generated compounds.Keywords: Chlorpromazine, Breast cancer, Drug repositioning, Laser-irradiated drugs, Antipsychotic drugs, ADME-ToxSubject terms: Cell biology, Computational biology and bioinformatics, Drug discovery Background Despite significant medical advancements, breast cancer remains a global health challenge. In 2020 breast cancer was the second leading cause of death for women, being responsible for, approximately 685,000 deaths which remains1. Alarmingly, predictions indicate a rise in new cases to over 3 million by 2040, with a potential death toll reaching 1 million, as reported by Arnold et al.2. The current treatments for cancer encompass surgery, chemotherapy, radiotherapy, endocrine therapy, and molecular targeted therapy3. Due to their anticancer properties, there is a growing interest in exploring the potential role of antipsychotic drugs in cancer treatment. Both first generation (typical) and second generation (atypical) antipsychotic drugs, such as haloperidol, chlorpromazine (CPZ), pimozide, penfluridol, thioridazine,, aripiprazole, or clozapine, have shown anticancer effects4. For instance, aripiprazole, a second-generation antipsychotic, has demonstrated inhibitory activity in the MCF-7 breast cancer cell line, as highlighted by Badran et al. and Lee et al.5,6. First-generation antipsychotics, including thioridazine, penfluridol, pimozide, CPZ, and trifluoperazine, also exhibit anti-cancer properties. CPZ, a typical antipsychotic from the phenothiazines class, has shown notable anticancer effects, such as inducing apoptosis and inhibiting DNA synthesis4,7. Several studies have highlighted CPZ’s inhibitory activity on breast cancer cell lines. Yang et al. study suggests that CPZ inhibits the HIPPO signaling pathway in a dose-dependent manner in the MCF-7 cell line, possibly through the promotion of proteasomal degradation, resulting in a reduction of chemotherapy resistance in cancer stem cells8. In other studies, CPZ treatment induced mitotic arrest in MCF-7mp54 and MDA-MB-231 breast cancer cells9. Laser exposure of phenothiazine derivatives, such as thioridazine, or CPZ, represents a promising approach to address bacterial infections and counteract antibiotic resistance. Upon exposure to 266 nm lasers, phenothiazines, including CPZ, undergo modifications in their absorption/fluorescence spectra by changing molecular structure. Resulted photoproducts demonstrate enhanced antibacterial efficacy, exhibiting significant time-dependent inhibition of Gram-positive bacterial strains and antibiofilm effects across a diverse bacterial strains10,11. In another investigation, the binding affinity of 15 phenothiazines, encompassing thioridazine and CPZ, against the main protease (Mpro) of SARS-CoV-2 is predicted through molecular docking. This study also explores the interaction of thioridazine and CPZ with their laser generated photoproducts. Thioridazine and its photoproducts show high biological activity against the virus’s main protease, implying their potential as innovative treatment options12. Furthermore, irradiated CPZ in the treatment of pseudotumor tissues in rabbit eyes highlights that the overall effects suggest an accelerated recovery of tissues in rabbit eyes compared to untreated eyes in the control group13,14. These findings underline the versatility and promising applications of laser-modified compounds in infectious diseases, antimicrobial resistance, and antitumor activity on pseudotumor. Our study aims to evaluate the biological activity of CPZ photoproducts generated after laser irradiation, comparing their effects on both normal (MCF12-A) and cancerous breast cells (MCF-7) with those of non-irradiated CPZ. Additionally, we predict the ADME-Tox and interactions between CPZ and previously identified photoproducts by liquid chromatography–time-of-flight mass spectroscopy (LC-TOF/MS)15.This is the first study showing the effects of irradiated CPZ in comparison with non-irradiated CPZ on human breast cancer. Our research contributes to the understanding of the potential benefits and applications of laser-modified compounds in cancer treatment, ultimately leading to the development of new therapeutic drugs. Materials and methods Chlorpromazine solution Chlorpromazine hydrochloride (CPZ, Sigma-Aldrich, US) was dissolved in distilled water at a concentration of 2 mg/mL, stored at 4 °C, and protected from environmental light before and after the irradiation protocol. Irradiation protocol CPZ samples, each with a volume of 2 mL, were placed into 1 cm optical path spectrophotometric cell and underwent irradiation separately for 5, 10, 20, 40, or 60 min using the fourth harmonic generation of a Nd: YAG pulsed laser (266 nm wavelength, Surelite II model, Continuum). The sample irradiation was performed using an average pulse energy of 6.5 mJ/pulse at 10 Hz and 6 ns full time width at half maximum) through two dichroic mirrors (Fig. 1), following the irradiation protocol detailed in Alexandru et al.15. The samples were kept under continuous stirring (600 rpm) during irradiation. The area of the beam spot on the cell was 0.38 cm2 (0.7 cm diameter) meaning an irradiance (average power density) equivalent to 171 mW/cm2. In the case of each sample the irradiation dose is determined by the time of irradiation16. Thus, for 5, 10, 20, 40, and 60 min irradiation time intervals, the light doses are 0.05, 0.10, 0.20, 0.40, and 0.60 kJ/cm2, respectively. The laser pulse energy was monitored with an energy meter (QE25LP-H-MB-D0 model, Gentec EO, Canada). Experimental setup for CPZ irradiation protocol. Characterization of irradiated samples The absorption spectra were recorded between 200 and 600 nm with a UV-Vis spectrophotometer (model Lambda 950, Perkin Elmer, US) using spectrophotometric quartz cells of a 1 cm optical path. The spectral resolution was 0.05 nm, and the measuring error limit was ± 0.004%. To avoid absorption saturation, the CPZ non-irradiated and irradiated solutions were diluted tenfold before spectra measurements. The IR absorption spectra were recorded using FTIR Nicolet™ iS™50 spectrometer (Thermo Scientific, US), between 1600 and 700 cm− 1, at 4 cm− 1 resolution, and for an average of 32 scans. A volume of 20 µL of sample was dried on a KRS-5 (Thallium Bromo-Iodide) support and measured in transmission mode. In silico approach Molecular modeling For our studies, we used the photoproducts identified by Alexandru et al.15 using LC-TOF/MS. Several chemical structures for the photoproducts resulted from the interaction of 266 nm laser radiation (6.5 mJ) with aqueous CPZ solutions (2 mg/mL) irradiated as in our protocol at different time intervals, including 5 and 60 min. These are as follow: chlorpromazine-sulfoxide (CPZ_SO, C17H20ClN2OS), promazine (PZ, C17H21N2S), hydroxy promazine (PZ_OH, C17H21N2OS), 2-hydroxy promazine sulfoxide (PZ_OH_SO, C17H21N2O2S), promazine sulfoxide (PZ_SO, C17H21N2OS) and other 2 compounds labelled P1 (C15H14ClNOS) and P2 (C15H14ClNO2S). The 2D chemical structure of CPZ was obtained using the SMILES code from the PubChem database17. The chemical structure of the photoproducts was drawn using Marvin Sketch. The optimization of molecules was performed in Discovery Studio software and saved in .mol2 format18. After optimization, Open Babel software was used to convert the molecules to .pdbqt format19. Drug-likeness evaluation of photoproducts The Lipinski and Veber rules for drug-likeness were applied to the photoproducts to identify promising candidates as potential drugs. For ease of prediction, we utilized the SwissADME online platform20. ADME-Tox predictions Prior to conducting the in vitro approaches, we employed pkCSM and pro-toxII webservers to predict the Absorption, Distribution, Metabolism, Excretion (ADME), and toxicity profile of CPZ and its photoproducts21. These simulations were made to assess the suitability of the compounds for future in vitro testes by providing preliminary information’s into their pharmacokinetic and toxicological potential. In vitro approach Cell culture and treatment Human breast adenocarcinoma MCF-7 (ATCC HTB-22; ATCC/LGC Standards GmbH, Wesel, Germany) and human breast non-tumoral MCF-12 A (ATCC CRL-10782) cell lines were utilized to assess the effectiveness of the CPZ solutions in vitro. The cells were cultivated in 75 cm2 flasks within a humidified atmosphere at 37ºC and 5% CO2, with passages conducted twice a week. MCF-7 epithelial cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, 31600-083; Life Technologies Gibco, Paisley, UK) supplemented with 3.5 g/L glucose, 1.5 g/L NaHCO3, 1% antibiotic-antimycotic mix (A5955; Sigma-Aldrich, St. Louis, MO, USA), and 10% fetal bovine serum (FBS, 10270-106; origin South America, Life Technologies Gibco, Carlsbad, CA, USA). The complete growth medium for normal MCF-12 A epithelial cells was prepared from a 1:1 mixture of DMEM and Ham’s F12 medium (32500-035; Life Technologies Gibco, Paisley, UK), 1.5 g/L NaHCO3, 20 ng/mL human epidermal growth factor, 100 ng/mL cholera toxin, 0.01 mg/mL bovine insulin, 500 ng/mL hydrocortisone, 1% antibiotic-antimycotic mix, and 10% FBS. Laser irradiated CPZ solutions were sterilized using 0.22 μm pore size filters and applied to culture media at various concentrations (5, 10, 15, 20, 30 µM). Untreated cells were used as a control. The cells were incubated for 24 h before biological assessment. Cell viability assay Cell viability was evaluated using the water-soluble tetrazolium salt, MTS (3-[4,5-dimethylthiazol-2-yl]-5-[3-carboxymethoxy-phenyl]-2-[4-sulfophenyl]-2 H-tetrazolium, inner salt) (ab197010; Abcam, Cambridge, UK). The MTS assay was conducted following the manufacturer’s instructions. Briefly, MCF-7 and MCF-12 A cells were seeded in 96-well plates at a density of 3 × 104 cells/mL and 2 × 104 cells/mL, respectively, treated with the tested compounds for 24 h, and then incubated with MTS solution for 2 h. The optical density was measured at 490 nm using a microplate reader (FlexStation 3 microplate reader; Molecular Devices LLC, San Jose, CA, USA). The IC50 values of all CPZ solutions were determined for both MCF-7 and MCF-12 A cells using GraphPad Prism software (version 8.0.2, GraphPad Software, La Jolla, CA, US). LIVE/DEAD assay A LIVE/DEAD Viability/Cytotoxicity kit (L3224; Invitrogen, Life Technologies, Oregon, USA) was used to determine the cytotoxic potential of CPZ photoproducts on MCF-7 and MCF-12 A cells. The kit uses calcein acetoxymethyl ester (AM) and ethidium homodimer (EthD-1) for staining live (green) and dead (red) cells within the same cell population. Thus, 24 h from treatment, a solution of calcein AM: EthD-1 (2 µM: 4 µM) prepared in FBS-free medium was applied to breast cells and incubated for 20 min at room temperature. The cells were visualized under an Olympus IX73 fluorescence microscope (Olympus, Tokyo, Japan) equipped with a Hamamatsu ORCA-03G camera (A3472-06, Hamamatsu, Japan). Representative fields were captured using the CellSens Dimension Software. Detection of LDH leakage The amount of LDH released in the culture medium is an indicator of the cell membrane integrity and cytotoxicity of compounds. This investigation utilized the Cytotoxicity Detection Kit (LDH), ver. 11 (11644793001, Roche, Basel, Switzerland), following the manufacturer’s instructions. In brief, cells were seeded in a 96-well plate and allowed to adhere overnight. After 24 h of exposure to the tested compound, a volume of 50 µL of culture supernatant was homogenized with a volume of 50 µL of reaction mix consisting of a catalyst and dye solution (1:45). The plate was then incubated for 15 min in the dark, and the absorbance was read at 490 nm using a FlexStation 3 microplate reader (Molecular Devices, San Jose, CA, US). Detection of reactive oxygen species (ROS) To evaluate the capacity of CPZ to induce reactive oxygen species (ROS) production, MCF-7 and MCF-12 A cells were seeded into black 96-well plates with transparent bottoms. Following cell adhesion, the culture medium was removed, and cells were washed once with Hank’s Balanced Salt Solution (HBSS). Subsequently, 100 µL of a 25 µM H2DCFDA solution was added to each well, and the plates were incubated in the dark at 37 °C for 45 min to allow for cellular uptake and ester hydrolysis of H2DCFDA. After incubation, excess H2DCFDA was removed, and the cells were treated with CPZ solutions. Fluorescence of the oxidized DCF product, expressed as relative fluorescence units (RFU), was measured at 24 h post-treatment using a multi-plate reader with excitation/emission settings of 485 nm/520 nm, respectively. Assessment of nitric oxide production The release of nitric oxide (NO) into the culture medium was assessed by measuring the accumulation of nitrite, a stable metabolite of NO, through the Griess reaction, as previously described22. Briefly, the cells were seeded in a 96 well-plate and treated with irradiated CPZ solutions. After 24 h, a volume of 80 µL of culture supernatant was mixed with 80 µL of Griess reagent containing 0.1% naphthyl-ethylene diamine, 1% sulfanilamide, and 6% phosphoric acid. The absorbance was measured at 540 nm, and nitrite concentration was determined using a standard curve of serial dilutions generated with sodium nitrite diluted in culture medium (concentrations from 0.1 to 100 µmol/L). Fluorescence staining of F-actin MCF-7 and MCF-12 A cells were seeded in 24-well plates and incubated overnight. After 24 h from treatment with irradiated CPZ solutions, cells were fixed with cold 4% paraformaldehyde in PBS for 20 min at 4ºC, permeabilized with a mix of 0.1% TRITON X-100 and 2% BSA prepared in PBS for 45 min at room temperature. F-actin filaments were stained with phalloidin conjugated to Alexa Fluor 488 (150 nM, A12379; Invitrogen, Life Technologies, Oregon, USA) for 45 min at room temperature under gentle agitation. Staining of nuclei was performed with Hoechst (2 µg/mL, H6024; Sigma, St. Louis, MO, US) for 10 min at room temperature. The cells were examined using an Olympus IX71 fluorescence microscope (Olympus, Tokyo, Japan) and the CellSens Dimension software. Statistical analysis Data were expressed as mean ± SD of three separate experiments (n = 3). Results were represented as percentages and statistically significant differences among the control and treated samples as well as between non-IR and IR conditions were determined using two-way ANOVA variance followed by Dunnett’s and Tukey’s multiple comparisons test, respectively. All statistical analysis was conducted using GraphPad Prism software (version 8.0.2, GraphPad Software, La Jolla, CA, US). Results and discussions Characterization of irradiated samples The interaction of laser radiation with CPZ solution samples was evaluated based on their UV-Vis and IR absorption spectra measured after each laser beam exposure session to understand the photoproducts’ formation pathways. The absorption spectrum of the control (unirradiated) CPZ solution exhibits peaks in UV at 254 nm and 304 nm (Fig. 2). The maximum at 254 nm is characterized by a high molar extinction coefficient corresponds to a π – π* transition, while the wider absorption band centred at 304 nm is due to n – π* transitions23. The UV-Vis absorption spectra of 2 mg/mL CPZ solutions in distilled water irradiated at 266 nm, 6.5 mJ/pulse energy, for time intervals between 5 and 60 min (solutions were diluted 10 times to avoid spectra saturation). The exposure to laser radiation of 6.5 mJ energy emitted at 266 nm for up to one hour induces molecular changes that are reflected in the UV-Vis absorption spectra (Fig. 2). The 254 nm absorption maximum is shifted towards longer wavelengths with the increase of irradiation time, while its absorbance decreases. For the absorption band centered at 304 nm, a hypsochromic shift was registered during laser beam irradiation, and its allure was prone to flatten by the end of the irradiation session of 60 min. This behavior can be a consequence of the pH modification of solutions during irradiation or polarity changes23,24. Another absorption peak appears in the spectra at longer irradiation periods (40 and 60 min), located around 360 nm. These changes in the UV-Vis spectra suggest the formation of new compounds due to modifications in the functional groups of the phenothiazine ring25. The spectra in Fig. 2 highlight two isosbestic points located in two spectral intervals: between 225 and 250 nm, and respectively 259–262 nm. Their position changes function of the irradiation time. For example if considering the 5 min of laser beam exposure, the two isosbestic points are identified at 226 nm and 261 nm. Afterwards, for prolonged irradiation sessions the first intersection point shifts to longer wavelengths as the second moves to lower ones. These kinetics of the isosbestic points recorded in the UV-Vis absorption spectra of CPZ under the influence of laser radiation suggest the formation of reaction intermediates in significant concentrations, the presence of more chemical species that absorb energy in equilibrium, or photochemical interactions between the absorbing species in irradiated solutions23,26,27. Pascu et al.. reported thatCPZ completely vanished after 30 min when the laser’s energy level was 6.5 mJ. More polar species were produced that become noticeably within 1 min irradiation and their amount continue to grow until they reach their maximum when the entire native CPZ has vanished (30 min)24. This is supported also by the modifications of the absorption spectra for 60 min of irradiation in the current study: the CPZ characteristic band at 304 nm disappears, the 254 nm peak is shifted to longer wavelength and a new peak appears at 360 nm probably due to oxidated species formation28. FTIR spectra have been recorded in the MIR spectral range for unirradiated/control and laser-irradiated samples, and they are plotted in Fig. 3 for the 1600 cm− 1 − 700 cm− 1 spectral range. FTIR spectra of unirradiated and laser-exposed 2 mg/mL CPZ solutions in distilled water plotted in 1600 cm− 1 − 700 cm− 1 spectral range. The characteristic IR vibrations identified from the spectrum of unirradiated CPZ are summarized in Table 1. Table 1The type of vibration identified for unirradiated CPZ.Type of vibrationFrequency [cm-1]Stretching vibration of the aromatic ring C = C-C1590 & 1560Stretching vibration of C-H from 1457=C-H in-plane deformation vibrations of 4-adiacent H atoms of the ring system1282Aromatic = C-H in-plane deformation vibrations-wagging1250–1000In-plane deformation vibrations-scissoring of C-H from ()1150 –900C-N stretching vibration1180–865Stretching vibration C-Cl804Out-of-plane bending vibration of 4-adiacent H atoms of the ring system755 The type of vibration identified for unirradiated CPZ. The laser beam induces spectral changes when compared to the IR spectrum of unexposed samples. The appearance of new bands or the vanishing of others in the case of laser-irradiated solutions evidence the formation of photoproducts. Photoisomerization, photoaddition and cycloaddition, photosubstitution, intramolecular photocyclization, photorearrangement, photo-reduction, and oxidation are the main photochemical transfer reactions in an aromatic structure29. When exposed to UV light, CPZ is known to be transformed into its metabolites through ring hydroxylation, oxidation of nitrogen or sulfur, and N-chain demethylation30. The main metabolite in the photolytic transformation of CPZ, chlorpromazine sulfoxide (CPZ-SO) is obtained by the direct reaction of chlorpromazine with molecular oxygen. It is also likely to be produced through hydrolysis of the CPZ radical cation24,31. Intensity decreases of the characteristic vibrations for CPZ exposed for more than 20 min to laser radiation occurs in the 1590 cm− 1 − 1560 cm− 1 spectral range, corresponding to stretching vibration of the aromatic ring C = C − C. This is accompanied by the raising of a new band centred at 1552 cm− 1 attributed to the stretching vibration of the C–O bond of a phenol, which is an indicative for the formation of a hydroxyl photoproduct. The shift of the peak registered at 1457 cm− 1 together with the vanishing of the shoulder at 1483 cm− 1, bands assigned to C − H bending vibrations, indicates the demethylation and formation of the photoproductsP1, and P2 (see Table 2). Furthermore, this is supported by the disappearance after 20 min of laser beam exposure of the bands due to the CH2 wagging vibrations that occurs near 1300 cm− 1 and of the more intense band at 1457 cm− 1 dependent on the number of CH2 groups32. Table 2Compound name SMILES code, 2D structure, Lipinski’s Ro5 and Veber drug-like evaluation.CompoundSMILESStructureVeberRo5CPZ_SOClc1cc2N(c3c(S(= O)c2cc1)cccc3)CCC[NH+](C)C YESYESP1Clc1cc2N(c3c(Sc2cc1)cccc3)CCCO YESYESP2Clc1cc2N(c3c(S(= O)c2cc1)cccc3)CCCO YESYESPZS1c2c(N(c3c1cccc3)CCC[NH+](C)C)cccc2 YESYESPZ_OHS1c2c(N(c3c1cccc3)CCC[NH+](C)C)cc(O)cc2 YESYESPZ_OH_SOS1(= O)c2c(N(c3c1cccc3)CCC[NH+](C)C)cc(O)cc2 YESYESPZ_SOS1(= O)c2c(N(c3c1cccc3)CCC[NH+](C)C)cccc2 YESYES Compound name SMILES code, 2D structure, Lipinski’s Ro5 and Veber drug-like evaluation. The vanish of the band at ~ 1139 cm− 1 (C-N stretching vibration) suggests a breaking of the aliphatic amine chain and can occur after 20 min laser beam irradiation. This can have as effect the formation of the same P1, P2 photoproducts. The changes in the aliphatic amine chain may induce the extinction of the 930 cm− 1 vibration due to aromatic C-N stretching observed at 1 h laser radiation exposure. The band arising at about 1206 cm− 1 after a few minutes of laser irradiation can be assigned to the formation of the oxidized species, CPZ-SO, PZ-SO being characteristic to the stretching vibration of the S = O bond. Literature reports proposed few ways for the development of sulfoxide compounds following the CPZ interaction with optical radiation. In aqueous solution, it is suggested that the molecular oxygen in direct reaction with phenothiazine results in the sulfoxide compound generation30,33. Baciocchi et al. proposed the possibility of the participation of singlet oxygen as an oxidant agent of CPZ ground state34. The sulfoxide compounds formation influences also the band centered at 1246 cm− 1 which corresponds to CH in-plane deformation vibrations of the central aromatic ring, this feature is decreasing with irradiation time and even disappears after 1 h laser exposure. The extinction of the band at 804 cm− 1 characteristics to C-Cl vibration emphasizes the formation of PZ. The formation of PZ can be a result of the dehalogenation of CPZ from the triplet state, the proposed process being the homolytic cleavage of the C–Cl bond followed by the hydrogen atom extraction from the solvent by the promazinyl radical35. The 7–8 cm− 1 shift towards longer wavenumbers, observed for all bands, can be explained by the CH2-part of the ethyl group upfield displacement as a consequence of the C-Cl break36,37. The possible pathways for the CPZ transformation as a result of its interaction with the laser beam at 266 nm was proposed in Alexandru et al.15. Fluorescence and phosphorescence emissions, energy transfer, internal conversion, singlet oxygen generation and photochemical transformation (homolytic cleavage of C-Cl and PZ formation, CPZ and PZ oxidation) are some of the potential deexcitation mechanisms of excited molecules following photon absorption by CPZ. According to Tozar & Pascu36, unirradiated CPZ solutions can be stored in the dark at 4° C for four weeks without losing any of their characteristics. After being subjected to laser radiation generated at 266 nm by the Nd: YAG laser, CPZ solution samples of 2 mg/mL stabilized after 24 h and remained stable for two weeks after the irradiation process. In the context of clinical translation, this information is essential, as stability is a key factor in the formulation of CPZ for clinical use. In silico approach Drug-like predictions The drug-like predictions were made using molecular descriptors: partition coefficient octanol/water (LogP(o/w), number of H-bond acceptors (HBA), H-bond donors (HBD), molecular weight (MW), Topological Polar Surface Area Å2 (TPSA) and the number of rotatable bonds (N_rotB) of photoproducts, computed using SwissADME20. SMILES code and drug-like rules validation for CPZ and its photoproducts are presented in Table 2. According to our predictions, CPZ and compounds previously identified after its laser irradiation adhere to both Veber and Lipinski’s rules (Table 2). ADME and toxicity predictions ADME-Tox predictions are important preliminary insights into the pharmacokinetic and toxicological behaviour of our identified photoproducts. Those predictions are useful to identify potential liabilities facilitating early-stage decisions. We have predicted the ADME-tox profile of the CPZ-identified photoproducts and compared it with the CPZ predictions. The results show a high similarity between the photoproducts’ ADME-predicted profiles and CPZ (Table 3). Table 3ADME predicted profile of CPZ and its photoproducts.CPZCPZ-SOP1P2PZPZ-OHPZ-OHSOPZ-SOCaco2 permeability (log Papp; cm/s)1.341.021.451.121.401.161.160.76P-glycoprotein I inhibitorYesNoNoNoNoNoNoNoP-glycoprotein II inhibitorYesYesNoNoNoNoNoNoFraction unbound (human)0.150.190.040.070.160.290.270.21CYP2C19 inhibitiorNoNoYesYesNoNoNoNoCYP2D6 inhibitiorYesYesNoNoYesYesYesNoCYP3A4 inhibitiorNoNoNoYesNoNoNoNoTotal clearance (ml/min/kg)0.930.980.180.401.011.001.051.06 ADME predicted profile of CPZ and its photoproducts. The Caco-2 is the human epithelial cell line used as an in vitro model to predict the absorption of orally administered drugs. In this in silico model, it is considered that compounds have high permeability if the predicted values are higher than 0.90 log of the apparent permeability coefficient (Papp). PZ-SO photoproduct has the lowest predicted Caco-2 permeability of the CPZ photoproducts (0.76 Log Papp; cm/s) indicating a moderate Caco-2 permeability (Table 3). According to our prediction presented in Table 3, the photocompounds of CPZ have high Caco-2 permeability, similar to CPZ (Table 3). CPZ is a P-glycoprotein I and II inhibitor, while the photoproducts are not (except CPZ-SO, which is a P-glycoprotein II inhibitor) (Table 3). A compound that inhibits this glycoprotein may result in contraindications when administered with other compounds. The fraction unbound represents the degree of the compound that remains unbound to serum proteins. The higher the degree of an unbound compound, the higher the efficacy of the compound to cross or diffuse through the cellular membrane. Except for P1 and P2, which have a lower fraction unbound than CPZ, the photoproducts have a higher fraction unbound, indicating a possible better distribution compared with CPZ (Table 3). A compound that is a CYP inhibitor may affect drug metabolism. Our prediction considers a drug as a CYP inhibitor if the concentration required to lead to 50% inhibition is less than 10 μm for a given isoform. PkCSM predictions indicate that, unlike CPZ, photoproducts P1 and P2 are inhibitors of CYP2C19 but do not inhibit CYP2D6, suggesting a possible difference in metabolism. The photocompound PZ-SO is not an inhibitor of any of the CYP enzymes studied, whereas CPZ, as expected, is an inhibitor of CYP2D638. Photocompound P2 is the only compound that inhibits CYP3A4. Since P1, P2, and PZ-SO have different inhibitory activities compared to CPZ according to these predictions, they may interact differently with the metabolism of other drugs relative to CPZ (Table 3). The total clearance is a combination of hepatic and renal clearance of the drug, and it is important for determining the dose necessary to achieve the steady-state concentration of the compounds. Except for P1 and P2, the total clearance of the photoproducts is similar to that of CPZ indicating similar excretion. Regarding the toxicity predictions, in Table 4 we have predicted hepatotoxicity (dili), carcinogenicity (carcino), immunotoxicity (immune), mutagenicity (mutagen), cytotoxicity (cyto), and the lethal dose 50% (LD50) of the photoproducts and compared them with CPZ (Table 4). Table 4Toxicity profile of CPZ and its photoproducts.MoleculeDiliCarcinoImmunoMutagenCytotoLD50CPZ pred/ probA/0.54I/0.76A/0.58I/0.68I/0.52135 mg/kgCPZ-SO pred/ probI/0.61I/0.65I/0.74I/0.58I/0.51300 mg/kgP1 pred/ probI/0.59I/0.66I/0.70I/0.68I/0.63300 mg/kgP2 pred/ probI/0.64I/0.66I/0.90I/0.59I/0.561000 mg/kgPZ pred/ probI/0.56I/0.77I/0.85I/0.65I/0.57210 mg/kgPZ-OH pred/ probI/0.72I/0.70A/0.64I/0.53I/0.59408 mg/kgPZ-OHSO pred/ probI/0.76I/0.61I/0.69I/0.51I/0.55370 mg/kgPZ-SO pred/ probI/0.74I/0.63I/0.90I/0.55I/0.54140 mg/kg“A” stands for active, and “I” for inactive Toxicity profile of CPZ and its photoproducts. “A” stands for active, and “I” for inactive The predicted results indicate that: (i) CPZ is a hepatotoxic compound, while the photoproducts may not be; (ii) CPZ and CPZ-OH compounds exhibit immunotoxicity, while the other photoproducts do not. CPZ and its photoproducts are inactive as carcinogenic, mutagenic, and cytotoxic compounds. The LD50 (mg/kg) is higher for the photoproducts compared to CPZ (Table 4). Since safety is a primary concern in the context of further clinical translation, the potential side effects related to the compounds obtained after laser-irradiation as well as the pharmacological effects, must be analysed. Consequently, at this early stage, the ADME-Tox properties predictions of the photoproducts represent a mandatory evaluation. Our results indicate that the photoproducts may offer a safer alternative for therapeutic applications compared to CPZ, justifying further investigation. In vitro approach Cytotoxicity of CPZ photoproducts and ROS production Tumorigenic (MCF-7) and normal (MCF-12 A) human breast cells were exposed to laser irradiated and non-irradiated CPZ for 24 h at concentrations ranging from 5 to 30 µM consistent with previously established effective doses for CPZ7. As shown in Fig. 4 the cytotoxic effects of CPZ photoproducts are dependent on dose and irradiation time. In the absence of irradiation, CPZ is toxic for both MCF-7 (Fig. 4A) and MCF-12 A (Fig. 4B) cells, beginning with a dose of 20 µM, where cell viability significantly decreased by 24% and 65%, respectively compared to control. Photoproducts of CPZ formed after 5 to 60 min irradiation showed increased efficiency in causing cell damage. Cell viability dropped severely at concentrations of 15, 10 and 30 µM. However, after 60 min of laser irradiation, the harmful effects of CPZ reach a plateau in potency. This was indicated by the level of viability after treatment of cells with a dose of 10 µM. Additionally, we noticed that MCF-12 A cells seemed less responsive than MCF-7 malignant cells at concentrations above 15 µM, which could potentially suggest a selective effect of CPZ photoproducts for tumoral cells. The IC50 values (Table 5) differed across conditions: non-irradiated CPZ yielded an IC50 of 27.02 µM in MCF-7 cells and 19.44 µM in MCF-12 A cells. CPZ irradiated for 10 min exhibited an IC50 of 15.20 µM in MCF-7 cells and 18.28 µM in MCF-12 A cells. Photoproducts of CPZ generated after 40 min of irradiation, produced the lowest IC50 values in MCF-7 of 10.75 µM while the IC50 in MCF-12 A cells was 11.46 µM. Cell viability evaluation by MTS assay. (A) MCF-7 and (B) MCF-12 A cells were exposed to CPZ solution irradiated for 0, 5, 10, 20, 30, 40, and 60 min; The irradiated CPZ solution was applied to the cells at different concentrations of 5, 10, 15, 20, and 30 µM for 24 h. The control is represented by untreated cells. Results (n = 3) are expressed in percentages compared to control cells (100%) ± standard deviation (SD). Statistical significance between the control and treated sample (*) was determined using two-way ANOVA followed by Dunnett’s multiple comparison test while differences between non-IR and IR conditions (#) were assessed using two-way ANOVA with Tukey’s multiple comparison test. Results were significant at *(#) p < 0.05; **(##) p < 0.01; *** (###) p < 0.001. Table 5Inhibitory concentration (IC50) values for non-irradiated and irradiated CPZ in MCF-7 and MCF-12 A breast cells.IC50 (µM)MCF-7MCF-12 ACPZ27.02 ± 1.2619.44 ± 2.77CPZ IR 5 min16.23 ± 1.2219.79 ± 1.35CPZ IR 10 min15.20 ± 0.4218.28 ± 1.26CPZ IR 20 min12.53 ± 0.6712.67 ± 0.72CPZ IR 40 min10.75 ± 0.4811.46 ± 0.08CPZ IR 60 min11.89 ± 0.2211.30 ± 0.48Values are expressed in µM ± SD Inhibitory concentration (IC50) values for non-irradiated and irradiated CPZ in MCF-7 and MCF-12 A breast cells. Values are expressed in µM ± SD These values demonstrate increased cytotoxicity of irradiated CPZ compared to non-irradiated CPZ in both normal and cancerous cells, especially at longer irradiation times. Based on MTS assay results, we selected three concentrations of CPZ (10, 15, and 20 µM) for further investigation, as these showed significant variability in cell viability between MCF-7 and MCF-12 A cells treated with both irradiated and non-irradiated CPZ. First, we demonstrated the capacity of CPZ photoproducts to induce cell death in MCF-7 (Fig. 5A) and MCF-12 A (Fig. 5B). To distinguish between live and dead cells, we have used two compounds, calcein AM and ethidium homodimer (EthD-1). Live cells exhibit ubiquitous intracellular esterase activity that produces the conversion of nonfluorescent calcein AM to highly green-fluorescent calcein in the cytoplasm. EthD-1, on the other hand, enters cells with compromised membranes and intensifies fluorescence upon binding to nucleic acids, emitting bright red fluorescence in dead cells. In the presence of non-irradiated CPZ, both MCF-7 and MCF-12 A cells exhibited predominant green fluorescence across all tested concentrations (10, 15, and 20 µM). However, a notable decrease in cell density of both cultures was observed following treatment with 15 and 20 µM CPZ, likely attributable to inhibited proliferation. Live/Dead fluorescence microscopy images showing the capacity of CPZ solution to induce cell death. (A) MCF-7 and (B) MCF-12 A cells were exposed to CPZ solution irradiated for 0, 10, and 40 min; The irradiated CPZ solution was applied to the cells in different concentrations of 10, 15, and 20 µM for 24 h. The control is represented by untreated cells. Viable cells are stained with calcein-AM (green fluorescence) and dead cells with EthD-1(red fluorescence). Scale bar: 100 μm. Upon laser irradiation of the CPZ solution for 10 min, a significant reduction in the number of viable MCF-7 cells was evident, accompanied by an increased number of dead cells, notably at a dose of 20 µM. Prolonged irradiation over 40-minute resulted in severe damage induced by CPZ photoproducts at doses of 15 and 20 µM, leading to the destruction of all cells. MCF-12 A cells exhibited comparatively less sensitivity to the same doses. Numerous studies conducted both in vitro and in vivo have demonstrated the diverse anti-cancer properties of CPZ alone, which include the activation of apoptosis as well as the suppression of multiple intracellular signaling pathways and DNA synthesis in different types of cancers4,39. In breast cancer cells, CPZ exhibits anti-proliferative effects, suppresses stemness and invasion, and enhances cancer cell sensitivity. The mechanisms involve the downregulation of the HIPPO-YAP signaling and increased membrane permeability, facilitating the accumulation of drugs8. Yang et al. showed that CPZ reduces the viability of breast cancer MCF-7 and MDA-MB231 cells to 50% after 48 h at a dose of 10 and 15 µM respectively. ore, it can inhibit the formation of MDA-MB231/CD44high/CD24low and MCF-7 spheroids8. Irradiated CPZ has not been previously employed in the treatment of breast cancer cells. Thus, the cytotoxicity of irradiated CPZ on human breast cancer and normal cells is demosntrated here for the first time. However, multiple studies have reported that the combination of CPZ with other chemotherapeutic drugs, such as doxorubicin, taxol, or tamoxifen, results in a notable reduction of breast cell proliferation and mammosphere-forming capacity compared to monotherapy. Additionally, this combination approach slows the growth of drug-resistant breast cancer cells and enhances their sensitivity8,40. Similarly, we demonstrate that applying a irradiation to CPZ could lead to increased sensitivity of breast cancer cells compared to non-irradiated CPZ as a result of the formation of new photoproducts with enhanced anti-tumoral efficacy. The cytotoxicity of CPZ photoproducts was also demonstrated through the analysis of LDH activity in cell culture supernatants as an indicator of membrane integrity. This determination substantially confirmed data obtained by MTS and LIVE/DEAD assays. A notable elevation in LDH leakage, reaching approximately 38% compared to the control, was observed in both MCF-7 and MCF-12 A cells following exposure to 20 µM CPZ irradiated for 10 min. As indicated in Fig. 6AB, treatment with CPZ irradiated for 40 min at concentrations of 15 and 20 µM, resulted in a significant increase in LDH activity in the culture medium, indicating distinct levels of cytotoxicity between cancerous and normal cells. Thus, the rise in LDH leakage was substantial in cancerous cells at concentrations of 15 and 20 µM CPZ irradiated for 40 min, reaching about 99% and 76%, respectively, while normal cells displayed a comparatively lower increase of 70% and 60%, respectively, relative to the control. These results confirmed the enhanced therapeutic efficacy of irradiated CPZ compared to non-irradiated CPZ and indicated the loss of membrane integrity at higher irradiation times and CPZ concentrations. This might be due to the interaction of CPZ with the breast cell membrane. According to a previous study, it was suggested that CPZ intercalates into hydrophobic areas of cell membranes and binds to negatively charged membrane surfaces, changing the permeability of the membrane40. The accumulation of reactive oxygen species (ROS) is a key indicator of oxidative stress in cells and serves as a major mediator of drug-induced cytotoxicity41. Thus, the production of ROS was assessed in MCF-7 and MCF-12 A cells in order to understand the mechanism of CPZ cytotoxicity. As shown in Fig. 6C, the results indicated a dose-dependent increase in ROS production in MCF-7 cancer cells treated with CPZ irradiated for 40 min, compared to the control sample. ROS levels rose by 133%, 534%, and 1015% at concentrations of 10, 15, and 20 µM, respectively. Smaller increases in ROS levels were also observed in MCF-7 cells treated with non-irradiated CPZ and CPZ irradiated for 10 min. Compared to non-irradiated CPZ, CPZ irradiated for 40 min solution induced a substantial accumulation of ROS at all three tested concentrations of 10 µM (# p < 0.019), 15 µM (### p < 0.0006), and 20 µM (## p < 0.0016), confirming the enhanced cytotoxicity of CPZ photoproducts generated after 40 min of irradiation. Evaluation of membrane integrity, ROS production and NO production. (A, C, E) MCF-7 and (B, D, F) MCF-12 A cells were exposed for 24 h to CPZ solution irradiated for 0, 10, and 40 min; The irradiated CPZ solution was applied to the cells in different concentrations of 10, 15, and 20 µM. Results (n = 3) are expressed in percentages compared to control cells (100%) ± standard deviation (SD). Statistical significance between the control and treated sample (*) was determined using two-way ANOVA followed by Dunnett’s multiple comparison test while differences between non-IR and IR conditions (#) were assessed using two-way ANOVA with Tukey’s multiple comparison test. Results were significant at *(#) p < 0.05; **(##) p < 0.01; *** (###) p < 0.001. Exposure to the same CPZ solution also led to a significant amplification in ROS levels in breast normal MCF-12 A cells (Fig. 6D), with increases of 98%, 318%, and 1055% over control levels at concentrations of 10, 15, and 20 µM, respectively. However, only at the concentration of 20 µM of CPZ irradiated for 40 min, the ROS increase was statistically significant compared to the non-irradiated CPZ at the same concentration (### p < 0.0005). Cancer cells are known to have higher levels of ROS, driven by their faster metabolism, genetic mutations, and low-oxygen environments. To manage this, they boost the antioxidant enzyme activity and enhance ROS removal mechanisms, thereby promoting cell survival. However, the elevated levels of endogenous ROS in cancer cells make them more sensitive to drug therapies that generate additional ROS than normal cells42. This increased sensitivity might explain the higher susceptibility of MCF-7 cells to ROS induced by CPZ compared to MCF-12 A cells. Previous research suggested that CPZ (non-irradiated) may decrease the mitochondrial membrane potential and induce the accumulation of ROS in several cell types43–45. However, the exact mechanisms of ROS generation remain less understood. Conversely, the photoactivation of CPZ in response to UVA/B irradiation has been shown to produce singlet oxygen and superoxide in the skin41. This process involves the conversion of CPZ to an excited state, followed by energy transfer to molecular oxygen. These reactive species can then interact with phospholipids, proteins, and DNA, potentially leading to adaptive or toxic responses. As indicated by our study, irradiation leads to the photolytic transformation of CPZ with the formation of several metabolites (e.g. PZ, PZ-SO, PZ-OH, PZ-OH-SO, CPZ-SO) which increase the intracellular ROS levels to a higher level compared to non-irradiated CPZ. These photoproducts may directly interact with cellular macromolecules, affect mitochondrial function, disrupt F-actin distribution, deplete cellular antioxidants, or activate specific signaling pathways that promote the production of ROS. Clarifying these mechanisms could provide insight into how the CPZ photoproducts contribute to increased oxidative stress in cells. Further, NO production was assessed as an indicator of the inflammatory potential of CPZ photoproducts in both human breast normal and cancerous cells (Fig. 6EF). In all conditions tested, the levels of NO remained unchanged following CPZ treatment. An exception was observed in MCF-12 A cells exposed to 15 µM CPZ irradiated for 40 min, where the NO level exhibited a slight increase of 10% in comparison with control. The absence of NO production in the breast cell culture medium after treatment may indicate that irradiated CPZ does not elicit an inflammatory response. Alternatively, it could suggest the lack of involvement of NO pathways in the cellular response to irradiated CPZ treatment in this context. Alterations of actin cytoskeleton As one of the primary targets of ROS overproduction, the F-actin cytoskeleton was evaluated in terms of integrity. The filamentous actin (F-actin) constitutes the predominant element within the cytoskeleton, formed through the polymerization of multiple G-actin units. Since, the actin cytoskeleton plays a pivotal role in various cellular processes, including maintaining cell homeostasis, cell movement, protein translocation, membrane dynamics, and cell death46, Furthermore, cytoskeletal proteins are regarded as promising therapeutic targets for metastatic cancer cells, given their important role in governing the migration and invasion of these cells47. Actin dynamics and remodeling can influence cellular responses to external stimuli by triggering various signaling pathways, mainly through the confinement of signaling proteins and their scaffolding along actin polymers48. To unveil the overall shape of the actin cytoskeleton of breast cells after treatment, F-actin filaments were stained with fluorescent phalloidin conjugates (Fig. 7AB). Notable alterations in both breast normal and cancerous cells were highlighted in the presence of irradiated CPZ solutions, with the extent of modifications dependent on the dosage. Fluorescent staining of F-actin filaments showing significant alterations of cytoskeleton after treatment with CPZ solutions. (A) MCF-7 and (B) MCF-12 A cells were exposed to CPZ solution irradiated for 0, and 10 min; The irradiated CPZ solution was applied to the cells in different concentrations of 10, 15, and 20 µM for 24 h. The control is represented by untreated cells. F-actin filaments (green fluorescence) were labeled with phalloidin conjugated to Alexa Fluor 488 dye and nuclei (blue fluorescence) were stained with Hoechst. Scale bar: 50 μm. Structural integrity modifications within the cytoskeleton induced by non-irradiated CPZ were significant, particularly at a dose of 20 µM. In MCF-7 cells, these alterations were predominantly characterized by the formation of membrane protrusions, while MCF-12 A cells exhibited actin filament aggregation. Upon treatment with CPZ photoproducts resulting from 10 min of irradiation, severe changes in MCF-7 cell morphology were observed at doses of 15 and 20 µM. These alterations consist of cell contraction, reduced cell volume, the emergence of multiple membrane extensions, wrinkled borders, and areas with cell membrane detached from the support. In parallel, MCF-12 A cells underwent deformation of cell shape, forming several membrane extensions, and reducing cellular volume, particularly at a dose of 20 µM. An irradiation of 40 min applied to CPZ resulted in widespread cell death, making it impossible to capture images of the cells. These findings suggest that the capacity of CPZ photoproducts to induce cell death in human breast cancer cells might be linked also to the disruption of F-actin organization following ROS production. We showed also that laser-irradiated CPZ can directly but differentially affect F-actin in breast cancer vs. normal cells, which consequently might decrease breast cancer cell attachment, migration, and invasion. Previous studies also indicated that F-actin in breast cancer cells exhibits greater sensitivity to perturbations induced by drugs or magnetic fields in comparison to non-tumoral cells. Moreover, non-tumoral cells fully recovered after drug retrieval, but not the MDA-MB231 and MCF-7 breast cancer cells47,49. The biological evaluation results confirm the anti-cancer activity of CPZ in the treatment of breast cancer and support its use in combination with laser pre-irradiation for enhanced effectiveness. Our findings indicate that breast cancer cells are more sensitive to the photoproducts generated by CPZ irradiation than to non-irradiated CPZ. We observed that the cytotoxic effects of these photoproducts are primarily associated with compromised cell membrane integrity, changes in F-actin filament organization, and a substantial increase in ROS production. The difference between the biological response of MCF-7 and MCF-12 A cells to the exposure to CPZ solutions may be further explored to identify mechanisms of selective cytotoxicity, optimize therapeutic dosing, and enhance the safety profile of CPZ-based treatments by minimizing potential effects on normal breast cells. Further studies will be conducted to unravel the biochemical and molecular mechanisms contributing to the anti-tumoral activity of CPZ photoproducts. Conclusions Laser-irradiation can offer a promising approach to enhance the anti-tumoral potential of non-anticancer drug, chlorpromazine. This research introduces a novel strategy by combining in-silico techniques, laser radiation, and in vitro validation to evaluate the anticancer properties of CPZ and its photoproducts. The investigation employs a specific irradiation protocol using a pulsed laser beam, revealing alterations in the UV-Vis and IR absorption spectra of CPZ, indicative of molecular changes. In silico analyses predict favourable drug-like properties, and ADME-tox predictions for CPZ and its photoproducts, adhering to established guidelines. In silico safety evaluations of the photoproducts are essential to identify any potential side effects associated with the use of irradiated CPZ. Our predictions indicate that CPZ photoproducts may have even a better tolerability than CPZ. Understanding the toxicity profile of the photoproducts in preclinical models will be critical for assessing their suitability for a possible future clinical setting. The in vitro approach evaluates the cytotoxic effects of CPZ and its photoproducts on breast cancer (MCF-7) and breast normal cells (MCF-12 A). The results demonstrate dose and irradiation time-dependent cytotoxicity, with photoproducts exhibiting enhanced efficacy compared to non-irradiated CPZ. Analyses employing membrane integrity, cell death detection, ROS and NO production confirm the selective cytotoxicity of irradiated CPZ toward cancerous cells. The study also explores the impact of CPZ and its photoproducts on the actin cytoskeleton, revealing significant alterations in cell morphology and F-actin organization. Overall, this research provides valuable insights into the anticancer potential of laser-modified CPZ compounds, paving the way for further investigations into their biochemical and molecular mechanisms. However, translating these findings into clinical applications necessitates careful consideration of several factors, including complete identification of the photoproducts resulted after irradiation of CPZ, the stability of the photoproducts, optimal delivery methods, and comprehensive safety. The main challenge lies in achieving and isolation of CPZ photocompounds. As well, assessing the photocompounds’ toxicity and their antitumor efficacy, both individually and also collectively in in vitro settings are important future requirements. Further studies on the identification and separation of CPZ photoproducts, the examination of their individual effects and interactions within the context of breast cancer therapy are challenges for potential clinical translation. Acknowledgements This research was funded by the Romanian Ministry of Research, Innovation, and Digitization under the CNCS-UEFISCDI within PNCDI III, project number PN-III-P1-1.1-PD-2021-0225, Nucleu Program LAPLAS VII contract no. 30 N/2023, and Institute of Atomic Physics through the project ELI-RO/RDI/2024_022. Author contributions A.M.U., A.S., and M.B. conceived the idea and experimental set-up; A.M.U., A.S., I.R.A., and S.A. conducted the irradiation protocol and performed the in silico experiments; A.M.U, M.A.B., and M.B. performed the in vitro experiments; A.M.U., M.A.B.; S.A., R.A.P. and M.B performed the statistical analysis of data and interpretation of results. A.S., S.A., M.L.P., and M.B. supervised the lab research work, and A.M.U. administrated the project. All authors participated in writing and reviewing the manuscript. Data availability All data generated or analysed during this study are included in this published article. The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request and with the permission of National Institute for Laser, Plasma and Radiation Physics and University of Bucharest. Declarations Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Angela Staicu, Email: angela.staicu@inflpr.ro. Mihaela Balas, Email: mihaela.balas@bio.unibuc.ro. References Associated Data Data Availability Statement All data generated or analysed during this study are included in this published article. The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request and with the permission of National Institute for Laser, Plasma and Radiation Physics and University of Bucharest.